This section keeps you updated on any major development throughout the course of the TIMESPAN project.
30 November 2021
2nd SC Meeting
Our 2nd SC meeting was held (once again) remote on 29 – 30 November 2021. Thank you all for your interesting updates as well as the great brainstorming sessions during the 2nd SC meeting! @orebrouni@karolinskainst@AarhusUni@UiB@researchumcg@vallhebron@KingsIoPPN@concentris_EU@EASOobesity@UpstateNews@empatica@hkumed#H2020#ADHD
3 October 2021
TIMESPAN at the 34th ECNP Congress
18 May 2021
KICK-OFF TIMESPAN meeting
The EU-funded research project TIMESPAN kicked off on May 18th – 19th 2021. The meeting was held remotely and although being held virtually it was full of vivid discussions as well as social interaction. 17 partners from all over the world joined forced evaluate the next steps that has to be taken in TIMESPAN. One of the main tasks was data harmonization as well as data access, definition of treatment discontinuity, and joined dissemination. All TIMESPAN scientific as well as ad hoc advisors also joined the meeting and provided a very valuable feedback on the project start.
1 April 2021
KICK-OFF TIMESPAN project
No April Fool’s joke, but the start of an exciting journey! Today, April 1st 2021, the 5 year-long EU-funded TIMESPAN project kicks off! 17 partners from academia, industry, and patient advocacy join forces in fostering improvements in clinical management of adults with #ADHD and co-occurring cardiometabolic disease.
Various national guidelines on cardiometabolic disease already highlight the importance of concurrent psychiatric disorders, but there is a lack of knowledge around ADHD. TIMESPAN strives to improve clinical outcomes, as well as Quality Of Life in adult ADHD patients with cardiometabolic disease.
23 June 2021
Focus group is currently established. The KCL team around Jonna Kuntsi is currently establishing a focus group who should be involved in the discussions on how to incorporate remote technology in the ADHD assessment and initial period of starting medication. In case you are interested in the participation please get in contact with: Hayley Denyer